Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotoxic therapy and resistance mechanism in gliomas. | Pharmacol Ther | 2021 | 34171339 | PubTator, text mining | PubMed |
| Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience. | Medicine (Baltimore) | 2021 | 34160418 | PubTator, text mining | PubMed |
| Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data. | EBioMedicine | 2021 | 34157484 | PubTator, text mining | PubMed |
| Racial and ethnic disparities in colorectal cancer incidence and mortality. | Adv Cancer Res | 2021 | 34148614 | PubTator, text mining | PubMed |
| Damage-Net: A program for DNA repair meta-analysis identifies a network of novel repair genes that facilitate cancer evolution. | DNA Repair (Amst) | 2021 | 34147942 | PubTator, text mining | PubMed |
| Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer. | Sci Rep | 2021 | 34145315 | PubTator, text mining | PubMed |
| Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. | NPJ Breast Cancer | 2021 | 34117267 | PubTator, text mining | PubMed |
| Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling. | J Clin Lab Anal | 2021 | 34114685 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. | J Crohns Colitis | 2021 | 34111282 | PubTator, text mining | PubMed |
| Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics. | Int J Med Sci | 2021 | 34104084 | PubTator, text mining | PubMed |
| Diverse immune response of DNA damage repair-deficient tumors. | Cell Rep Med | 2021 | 34095878 | PubTator, text mining | PubMed |
| Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC. | Theranostics | 2021 | 34093873 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| Identification of gastric cancer subtypes based on pathway clustering. | NPJ Precis Oncol | 2021 | 34079012 | PubTator, text mining | PubMed |
| Genetic and biological hallmarks of colorectal cancer. | Genes Dev | 2021 | 34074695 | PubTator, text mining | PubMed |
| Circulating Biomarkers of Colorectal Cancer (CRC)-Their Utility in Diagnosis and Prognosis. | J Clin Med | 2021 | 34071492 | PubTator, text mining | PubMed |
| Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome. | Cancers (Basel) | 2021 | 34067951 | PubTator, text mining | PubMed |
| From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas. | Cells | 2021 | 34067729 | PubTator, text mining | PubMed |
| Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript. | Int J Mol Sci | 2021 | 34067464 | PubTator, text mining | PubMed |
| Identifying Novel Actionable Targets in Colon Cancer. | Biomedicines | 2021 | 34065438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=49